APLM: Receives Nasdaq Notice
Apollomics receives Nasdaq deficiency notice regarding minimum market value requirement and updates rights for Vebreltinib in Asia
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.